Coronavirus Crisis: Main Thread

Moderators: Elvis, DrVolin, Jeff

Re: Coronavirus Crisis: Main Thread

Postby stickdog99 » Fri Oct 29, 2021 6:20 pm

https://twitter.com/ianmSC

With one of the strictest vaccine passport systems and an active mask mandate, cases in Lithuania continue to skyrocket and they now have the 6th highest case rate in the world

Image

Cases in Lithuania are 1,650% higher than Sweden, even though Lithuania has mask mandates and unbelievably strict vaccine passports…so based on this unequivocal failure, get ready for more expert and media demands to mandate masks and vaccine passports.

Image

The 7-day average of new cases in New Zealand is now the highest it’s ever been, which is odd because I was repeatedly yelled at by fanatical New Zealand COVID twitter their lockdown would immediately eradicate all transmission

I’m sure I’ll be getting my apology any day now

Image

I posted about Singapore yesterday, but it bears repeating that they reported the equivalent of 230,000 cases in the US the other day despite being 18.5 months into a mask mandate & with 85% of their population vaccinated

Image

Cases in Wales are the highest they’ve ever been with ~90% of everyone over 12 at least partially vaccinated,with an active mask mandate for over a year, and a new vaccine passport system

How much longer do we have to pretend The Experts™ have any idea what they’re doing

Image

Deaths are rapidly rising in Victoria, Australia with some of the most restrictive mask mandates on the planet, enforced by fines and aggressive policing…so it just goes to show you, if you mandate masks and strictly enforce compliance, your numbers will never go up

Image

Cases in Belgium are up 253% since they were praised for their “comeback” & being a “model for the world"

Naturally they have vaccine passports & ~75% of the population vaccinated, yet cases are exploding anyway

It’s important to remember The Experts™ are always, ALWAYS wrong.

Image

Cases in the South are now down 81% since Fauci said he didn’t think it was smart to have full college football stadiums, proving once again that we should always listen to The Experts™ because they know best

Image

Hospitalizations are rising faster in New Hampshire than in any other state in the country, despite ~100% of everyone over 65 at least partially vaccinated, so we have to ask yet again, why did Ron DeSantis do this to them?

Image

Hospitalizations in Vermont are rising again, with ~100% of everyone over 65 at least partially vaccinated for over 5 months but I’m sure that now we can get 5 year olds vaccinated we’ll finally be able to end the pandemic

Image

Hospitalizations in Colorado are up 275% in the past 3 months, even with 93% of everyone 65+ at least partially vaccinated

I wouldn’t expect this to get a lot of media attention though considering Colorado does not happen to be in the South or run by a Governor they don’t like

Image

Has anyone figured out yet why cases in Maine are so high, with nearly 90% of adults at least partially vaccinated?

The current case rate is nearly 4x higher than Florida

Not sure who’s more at fault here, DeSantis, Sturgis, or College Football fans

Image

Hospitalizations in Florida are down 86% in the past two months with no masks and no vaccine passports.

Congratulations go out to all of the politicians and experts who demanded masks and vaccine passports to bring the curve down

Image

For essentially the entirety of 2021, deaths have been higher in Germany than in Sweden, despite aggressive mask mandates and vaccine requirements in Germany, and few to no restrictions in Sweden

Wonder why we’re not seeing the media praise Sweden’s incredible COVID response

Image

2 weeks ago, LA County mandated vaccine passports for large events like theme parks & sporting venues + bars & other businesses. Orange County did not.

And what do you know, absolutely no difference & LA’s actually doing worse

The more The Experts™ fail, the more we need them

Image
stickdog99
 
Posts: 6562
Joined: Tue Jul 12, 2005 5:42 am
Blog: View Blog (0)

Re: Coronavirus Crisis: Main Thread

Postby stickdog99 » Fri Oct 29, 2021 7:08 pm

https://www.hartgroup.org/recent-deaths ... and-wales/

Recent deaths in young people in England and Wales
October 11, 2021

Increase in male mortality in 15-19 year olds should be investigated

Direct Mortality evidence

The mortality data for England and Wales from ONS from 1 May 2021 until 17 September 2021 shows a significant excess, particularly in the 15-19 year age group. Depending on the baseline chosen, the excess for 15-19 year olds is between 16% and 47% above expected levels (see table 1 and 2). COVID-19 deaths were too small in number to account for the excess. A disproportionate number of these excess deaths were in males. A certain amount of variation by random chance would be expected but an increase of this proportion is large enough not to be dismissed without further investigation.

Table 1 and Table 2: Mortality from 1st May 2021 to 17th September by age group. Table 1 uses a 2020 baseline and table 2 uses a mean from 2015-2019.

A clear deviation can be seen, beginning in May, for male deaths aged 15 to 19. Female mortality, on the other hand, shows a summer reduction more similar to 2020.

Image

Image

A similar magnitude of excess is seen in the 20-29 year old age groups, although background rates are higher. Comparing just deaths in males aged 15-19 year olds, there were between 52 and 87 excess deaths (depending on baseline). This clear predominance of male deaths could be in keeping with known risks of myocarditis which has a bias to men and boys. In 2015-2019 males accounted for 65% of deaths in the 15-19 year age group, rising to 70% in 20-29 year olds. If the entire excess had been due just to random variation we would have expected 65% of the excess to have been male. However, there were too many male deaths to reach that conclusion. There were 21 male deaths in excess of what would be expected with a normal male female ratio (2020 baseline) or 25 male deaths in excess (2015-2019 baseline).

Male excess deaths were calculated by subtracting male deaths from the baseline figures for male deaths. For 15-19 year olds there were 52 excess male deaths from 1 May 2021 to 17 September 2021 compared to 2015-2019 baseline, however there were only 44 excess deaths in total. This implies that there were fewer female deaths than expected in this period if using the 2015-2019 baseline.

In contrast, for the Mortality data for England and Wales from ONS from 1 January 2021 until 30 April 2021, there were only a small number of deaths above expected levels, almost all of which could be accounted for as COVID-19 deaths.

Image

Table 3 and Table 4: Mortality from 1st January 2021 to 30th April 2021 by age group. Table 3 uses a 2020 baseline and table 4 uses a mean from 2015-2019.

Myocarditis

Although concerns have been raised about a variety of adverse reactions to vaccination, the most serious and common thus far is the risk of myocarditis. Myocarditis is a serious condition associated acutely with fatal arrhythmias, and chronically, because myocytes are irreplaceable, with heart failure and significant associated mortality. As the aetiology of Covid-19 vaccine-induced myocarditis is new it may be unwise to extrapolate the prognosis from what is known about myocarditis due to other aetiologies. However, in the literature the overall mortality rate for myocarditis after one year is 20% and after five years 44% to 56%.

The incidence of myocarditis after COVID-19 vaccination increased with decreasing age and was higher in males.

Indirect evidence of mortality signals

There has been a clear rise in ambulance cardiac and respiratory arrest calls in England and ambulance calls for people becoming unconscious starting from May 2021 (see figures 1a and 1b). There were two periods of heatwaves which may have also impacted on the rise for a short period, but in general the rise remains otherwise unexplained. The timing and extent of the heatwaves are evident in the data on ambulance calls due to the direct impact of heat (see figure 1c).

Image

Image

Image

Figures 1a, 1b and 1c showing ambulance calls in England for cardiac and respiratory arrests (1a), unconscious patients (1b) and those impacted by heat or cold (1c)

Correlation with vaccination rollout

It is worth noting that the vaccine rollout began for vulnerable young people in winter so there isn’t a clear start date to look for an impact. However the clear majority of vaccinations were given in the 16 to 24 year olds from 1st May 2021 until recently.

Image

Figure 4 Daily first doses given by age in England

Image

Figure 5 Daily second doses given by age in England

Ref for data to plot numbers of doses given per day by age (Fig 61 of spreadsheet):

The data from PHE used to compile the above graphs is a comprehensive national system, the National Immunisation Management System (NIMS). However, although a proportion of data is collected promptly, there is a lag of a few weeks before the whole data set is complete. This lag means that the downward sloping from the beginning of September may well be artefactual. Nevertheless, it is clear that the majority of vaccinations in this age group were given since May.

PHE collects information on the vaccination status of patients who are registered with an NHS GP as part of NIMS. ONS have this data and have linked it to their death data in order to publish their document “Deaths involving COVID-19 by vaccination status, England: deaths occurring between 2 January and 2 July 2021”.

The information linking vaccination status to the deaths data is therefore available.

In their report, the ONS did not release the raw data but instead gave mortality rates adjusted for age. In this way a death of a young person contributes more to the age-adjusted mortality rate than a death of an older person, because the background numbers of deaths in the former age group are so much smaller than in the latter. The data shared with their paper shows a dramatic rise in non-COVID-19 mortality rate in those vaccinated more than 21 days earlier with a first dose, beginning in April 2021 and escalating rapidly in May 2021. Although some 18 and 19 year olds may have received a second dose in August, the majority (78% according to week 38 reported data) of the vaccinated 12-17 year population have received only a first dose. Therefore they would be largely in the category of “vaccinated more than 21 days earlier with a first dose”. The age adjusted mortality rate for this group reached levels 60% higher than the peak mortality rate for unvaccinated people during the winter.

Image

Figure 7 Age adjusted non-COVID mortality rates by vaccination status as published by ONS on 13th September

Ref for figure 7 (table 5 of their spreadsheet): https://www.ons.gov.uk/peoplepopulation ... tusengland

Summary

Mortality has risen in younger age groups since 1st May 2021. The increase in the 15-19 year old age group is particularly noticeable, especially as deaths in this age group are uncommon. The excess deaths have a marked male predominance. An increase in ambulance call outs for patients who have had a cardiac arrest or are unconscious showed a coincidental noticeable rise from May 2021. The period also coincides with the rollout of vaccination. Finally, ONS have reported on a striking rise in age adjusted mortality rates in those with only one dose that accelerated in May 2021 to levels far exceeding those in the unvaccinated.

Although there may be a number of explanations for these findings, further investigation of the cause of these deaths is warranted. The ONS death data and NIMS vaccination data have previously been linked. Without that link ONS could not have published on deaths after vaccination. Therefore, confirming the proportion of the 15-19 year olds that had been vaccinated should be possible.
stickdog99
 
Posts: 6562
Joined: Tue Jul 12, 2005 5:42 am
Blog: View Blog (0)

Re: Coronavirus Crisis: Main Thread

Postby stickdog99 » Fri Oct 29, 2021 8:12 pm

https://dailysceptic.org/2021/10/28/new ... e-as-well/

In any case, whatever the reason this study found a significant impact on transmission, a new study from Sweden has appeared that brings tidings from the other reality – the one where high observed levels of spread among the vaccinated translate to a decline to zero vaccine efficacy within months.

The study (a Lancet pre-print) finds that Pfizer vaccine effectiveness wanes from 92% at day 15-30 to 47% at day 121-180, and from day 211 (seven months) and onwards “no effectiveness could be detected”. For AstraZeneca, vaccine effectiveness “was generally lower and waned faster, with no effectiveness detected from day 121 [four months] and onwards”. (The figure they found was actually negative, minus-19%.)

While effectiveness against severe outcomes held up for many groups over nine months, it was found to wane significantly among men, older frail people, and people with comorbidities, contributing to an overall fall from 89% at day 15-30 to 42% from day 181 (six months) and onwards, with a number of subgroups even showing negative efficacy against severe outcomes.

The graphs included in the paper are reproduced below. Note the negative effectiveness against infection at nine months (top chart) and the effectiveness against severe outcomes down to around 20% at eight months (bottom chart).

Image

Image

The confirmation here of vaccine effectiveness against infection declining to zero will not come as a surprise to readers of the Daily Sceptic, though it may baffle readers of the New Scientist and others living in the parallel reality of highly effective vaccines. The sharp waning against severe disease is more of a surprise given recent data from PHE/UKHSA, and is worth watching closely.
stickdog99
 
Posts: 6562
Joined: Tue Jul 12, 2005 5:42 am
Blog: View Blog (0)

Re: Coronavirus Crisis: Main Thread

Postby stickdog99 » Fri Oct 29, 2021 8:32 pm

https://www.spectator.co.uk/article/why ... e-argument

I'm optimistic that the government won’t implement ‘Plan B’, let alone impose another lockdown — but not because sceptics like me have won the argument. Why do I say that? Because the public debate is about whether another lockdown is necessary, with the participants on both sides taking it for granted that non-pharmaceutical interventions are an effective way of suppressing infections. For at least a year, sceptics have been arguing that these don’t work, pointing to numerous research studies showing that the rise and fall of infections in different regions of the world has no correlation with stay-at-home orders, mask mandates, business and school closures, etc. But this argument has fallen on deaf ears.

One explanation — the one I like best — is that we made the mistake of trying to appeal to reason. This was a point made by David McGrogan, a professor at Northumbria law school, in a piece for my sceptical website. ‘I am somebody who encourages students to investigate and debate facts for a living. So this has been a very bitter pill for me to swallow indeed, but the reality is that most people are just not actually interested in finding out the truth for themselves. They are much more interested in conforming with what they perceive to be the “moral truth” — the prevailing moral norm.’ The reason the vast majority of the public supported lockdowns is because they believed they were the ‘right’ thing to do.

Of course, the lockdown enthusiasts wouldn’t have been so quick to conform to that ‘moral truth’ without believing that lockdowns actually did what they said on the tin. But I was astonished by how many intelligent people just swallowed the government line without subjecting it to proper scrutiny — particularly as lockdowns meant the surrender of our liberty on an unprecedented scale, as Lord Sumption has pointed out ad infinitum. It was as if such people were yearning for the social solidarity usually available only during wartime. And the flipside of that — denouncing anyone who refused the accept the restrictions — also had wide appeal. No doubt the government helped this process along by spending hundreds of millions bombarding us with propaganda, much of it designed by behavioural psychologists to penetrate our reptile brains.

But I think the sceptics have to accept some responsibility for their failings. Common sense dictates that if you confine most people to their homes then infections will start to fall, so if we’re going to persuade people that lockdowns don’t work we need a compelling theory as to why that hypothesis is false. We never came up with one. We also got a lot of things wrong at the beginning, such as saying there wouldn’t be a second wave and, when the second wave was upon us, claiming it was a ‘casedemic’ not an epidemic. I don’t think we got more things wrong than the enthusiasts —take their prediction that daily infections would rise to 100,000 after ‘freedom day’, for instance — but given that we were arguing against the prevailing wisdom we couldn’t afford to make any mistakes. In retrospect, I wish I’d been more cautious.

The reason I think another lockdown is unlikely is threefold. First, the vaccines. I don’t mean they’ve succeeded in suppressing infections where lockdowns failed: they do that a bit, but not much. Rather, Boris is reluctant to surrender the political capital he’s earned from the success of the vaccine rollout, which he would if he imprisoned us in our homes again. Second, public enthusiasm for lockdowns is waning, something evident from recent polling by Kekst CNC. In May, 61 per cent of the public prioritised limiting the spread of the virus over protecting the economy; today, it’s 42 per cent. I don’t know if that’s because nearly 80 per cent of adults are double-jabbed and less worried about catching it, or because the sense of social solidarity has faded. Probably a bit of both.

Finally, two of the most effective lobbyists for lockdowns in the government — Matt Hancock and Michael Gove — have both been moved. No doubt Michael still has Boris’s ear, but he’s no longer the de facto deputy prime minister driving Covid policy. Recent cabinet appointments have given Boris more room to manoeuvre and — whisper it — I’m almost certain he’s a lockdown sceptic. I would claim this as a victory, but I suspect he’s been one all along and just hasn’t been able to impose his will until now. So I think we’re in the clear, but it was no thanks to my small band of dissidents.
stickdog99
 
Posts: 6562
Joined: Tue Jul 12, 2005 5:42 am
Blog: View Blog (0)

Re: Coronavirus Crisis: Main Thread

Postby stickdog99 » Fri Oct 29, 2021 8:36 pm

https://brownstone.org/articles/22-stud ... opulation/

The evidence is pouring in that the COVID-19 vaccines are not as efficacious as advertised against the Delta variant that became dominant in the fall of 2021. The Delta is learning how to thrive. The evidence has further accumulated to show that the vaccinated are showing viral loads (very high) similar to the unvaccinated, and the vaccinated are equally as infectious.

The gestalt of the findings implies that the infection explosion globally – post double vaccination e.g. Israel, UK, US etc. – that we have been experiencing may be likely due to the possibility that the vaccinated are driving the epidemic/pandemic and not the unvaccinated. We have been vaccinating against the wild-type virus that is no longer a pressing concern, even if the vaccine data so far suggests effectiveness for the demographic most susceptible to severe outcomes.

The data seems to suggest that the infection is 50:50 (vaccinated versus unvaccinated) while the UK is reporting 70% of deaths in the vaccinated (Delta variant) though there is debate on differential based on < 50 versus >50 years old. It appears that it is the vaccinated who are getting infected and thus transmitting the virus at a far greater rate. This unravels the demand for universal vaccine passports.

The Marek’s disease (‘leaky’ non-sterilizing, non-neutralizing imperfect vaccines that reduce symptoms but do not stop infection or transmission) in chickens model, and the concept of the Original antigenic sin (if an initial exposure or priming of the immune system is sub-optimal (Eugyppius) e.g. vaccination with the 2020 spike protein epitopes, then the sub-optimal priming is basically “fixed.” That is to say, it prejudices the life-long immune response with re-exposure due to the immune memory or learning.

Here I present a combination of 22 studies and stories that underscore just how big a problem this is for the NIH, CDC, FDA, and vaccine developers. It certainly highlights the problems with vaccine mandates that are currently threatening the jobs of millions of people. It raises further doubts about the case for vaccinating children.

Cases in point:

1) Gazit et al. out of Israel showed that “SARS-CoV-2-naïve vaccinees had a 13.06-fold (95% CI, 8.08 to 21.11) increased risk for breakthrough infection with the Delta variant compared to those previously infected.”

2) Acharya et al. found “no significant difference in cycle threshold values between vaccinated and unvaccinated, asymptomatic and symptomatic groups infected with SARS-CoV-2 Delta.”

3) Riemersma et al. found “no difference in viral loads when comparing unvaccinated individuals to those who have vaccine “breakthrough” infections. Furthermore, individuals with vaccine breakthrough infections frequently test positive with viral loads consistent with the ability to shed infectious viruses.” Results indicate that “if vaccinated individuals become infected with the delta variant, they may be sources of SARS-CoV-2 transmission to others.” They reported “low Ct values (<25) in 212 of 310 fully vaccinated (68%) and 246 of 389 (63%) unvaccinated individuals. Testing a subset of these low-Ct samples revealed infectious SARS-CoV-2 in 15 of 17 specimens (88%) from unvaccinated individuals and 37 of 39 (95%) from vaccinated people.”

4) Chemaitelly et al. reported a Qatar study which showed that the vaccine efficacy (Pfizer) declined to near zero by 5 to 6-months and even immediate protection after one to two months were largely exaggerated.

5) A Siri reporting suggests that as high as 90% of hospitalizations in the US are among the vaccinated.

6) Riemersma et al. reported Wisconsin data that corroborate how the vaccinated individuals who get infected with the Delta variant can potentially (and are) transmit (ting) SARS-CoV-2 to others (potentially to the vaccinated and unvaccinated). They found an elevated viral load in the unvaccinated and vaccinated symptomatic persons (68% and 69% respectively, 158/232 and 156/225). This implied no difference between the vaccinated and unvaccinated in terms of carriage and transmission (symptomatic). Moreover, in the asymptomatic persons, they uncovered elevated viral loads (29% and 82% respectively) in the unvaccinated and the vaccinated respectively. This suggests that the vaccinated can be infected, harbour, cultivate, and transmit the virus readily and can be doing this unknowingly.

7) Subramanian reported that observed increases in COVID-19 are unrelated to levels of vaccination when they looked at 68 countries and 2947 counties in the United States. In other words, there is no clear discernable relationship (maybe a marginally positive association, where higher vaccination did not reduce the transmission).

8) Chau et al. (HCWs in Vietnam, Ho Chi Minh), looked at transmission of SARS-CoV-2 Delta variant among vaccinated healthcare workers in Vietnam, and their findings further ransacks the COVID-19 injection landscape and throws it into turmoil in terms of disastrous findings. 69 healthcare workers were tested positive for SARS-CoV-2. 62 participated in the clinical study. Researchers reported “23 complete-genome sequences were obtained. They all belonged to the Delta variant, and were phylogenetically distinct from the contemporary Delta variant sequences obtained from community transmission cases, suggestive of ongoing transmission between the workers. Viral loads of breakthrough Delta variant infection cases were 251 times higher than those of cases infected with old strains detected between March-April 2020”.

9) A CDC report by Brown in the MMWR (Barnstable, Massachusetts, July 2021) found that in 469 cases of COVID-19, there were 74% that occurred in fully vaccinated persons. “The vaccinated had on average more virus in their nose than the unvaccinated who were infected.”

10) Finland nosocomial hospital outbreak (spread among HCWs and patients): “In conclusion, this outbreak demonstrated that, despite full vaccination and universal masking of HCW, breakthrough infections by the Delta variant via symptomatic and asymptomatic HCW occurred, causing nosocomical infections.”

11) Israel nosocomial hospital outbreak (also spread among HCWs and patients) both revealed that the PPE and masks were essentially ineffective in the healthcare setting. The index cases were usually fully vaccinated and most (if not all transmission) tended to occur between patients and staff who were masked and fully vaccinated, underscoring the high transmission of the Delta variant among vaccinated and masked persons.

12) UK’s Public Health England Report # 42 on page 23 raised serious concerns when it reported that “waning of the N antibody response over time and (iii) recent observations from UK Health Security Agency (UKHSA) surveillance data that N antibody levels appear to be lower in individuals who acquire infection following 2 doses of vaccination.”

13) This UK report #42 (Table 2, page 13), as well as those reports 36 to 41, show a pronounced and very troubling trend, which is that the double vaccinated persons are showing greater infection (per 100,000) than the unvaccinated, and especially in the older age groups e.g. 30 years and above.

14) CDC’s Director Rochelle Walensky admitted that the vaccines are not stopping transmission which is an admission limits vaccine effectiveness.

15) Levin et al. “conducted a 6-month longitudinal prospective study involving vaccinated health care workers who were tested monthly for the presence of anti-spike IgG and neutralizing antibodies”…they found that “six months after receipt of the second dose of the BNT162b2 vaccine, humoral response was substantially decreased, especially among men, among persons 65 years of age or older….”

16) 40% of local Covid-19 cases in Syracuse, New York, are in the vaccinated.

17) Israel: One leading Israeli health official reported that the vaccinated are accounting for 95% of severe and 90% of new hospitalizations for COVID-19.

18) Suthar et al. examined the durability of immune responses to the BNT162b2 mRNA vaccine. They “analyzed antibody responses to the homologous Wu strain as well as several variants of concern, including the emerging Mu (B.1.621) variant, and T cell responses in a subset of these volunteers at six months (day 210 post-primary vaccination) after the second dose…data demonstrate a substantial waning of antibody responses and T cell immunity to SARS-CoV-2 and its variants, at 6 months following the second immunization with the BNT162b2 vaccine.”

19) Nordström in Sweden report on their study which shows that (cohort comprised 842,974 pairs (N=1,684,958), including individuals vaccinated with 2 doses of ChAdOx1 nCoV-19, mRNA-1273, or BNT162b2, and matched unvaccinated individuals) “vaccine effectiveness of BNT162b2 against infection waned progressively from 92% (95% CI, 92-93, P<0·001) at day 15-30 to 47% (95% CI, 39-55, P<0·001) at day 121-180, and from day 211 and onwards no effectiveness could be detected (23%; 95% CI, -2-41, P=0·07).”

20) CDC Director Rochelle Walensky’s and Dr. Fauci’s call for boosters basically tells you all you needed to know, that the vaccine has failed to live up to its most elaborate promises.

21) Yahi et al. reported that “in the case of the Delta variant, neutralizing antibodies have a decreased affinity for the spike protein, whereas facilitating antibodies display a strikingly increased affinity. Thus, ADE may be a concern for people receiving vaccines based on the original Wuhan strain spike sequence (either mRNA or viral vectors).”

22) Israel is prepping for a 4th booster shot; it reveals that the vaccine has not to live up to its inflated promise.

In conclusion, many people want the vaccine and they should be free to accept it as individuals. The public benefit of universal vaccination is now is grave doubt, and, as such, should not be expected to contribute to eliminating the social cost of the virus, much less be mandated by governments.
stickdog99
 
Posts: 6562
Joined: Tue Jul 12, 2005 5:42 am
Blog: View Blog (0)

Re: Coronavirus Crisis: Main Thread

Postby stickdog99 » Fri Oct 29, 2021 9:57 pm

https://ecosophia.dreamwidth.org/154971.html

As the health data is often convoluted, it might be interesting to look at the financial data. I took a look at Pfizers and Mercks second quarter report of 2021.

As expected Pfizer realized a huge increase in turnover. Besides the vax, they also make extra profit from sales of Vyndaqel/Vyndamax (for the treatment of Myocardiopathy) up +77% compared to Q2 2020 and Eliquis (for the treatment of blood clots) up +13%. Also an increase in the sales of various anti-cancer medicine. I leave it up to the commentariat to draw their conclusions… Source

Merck also reported a significant rise in oncological drugs and cardiovascular drugs (see pages 35 and 39)

The Q3 reports should be released in a few days, before the end of the month. Considering all the evidence we have seen here, it wouldn't surpise me to see continued high demand for drugs for cardiovascular problems, myocarditis, bloodclots and possibly cancer.
stickdog99
 
Posts: 6562
Joined: Tue Jul 12, 2005 5:42 am
Blog: View Blog (0)

Re: Coronavirus Crisis: Main Thread

Postby Belligerent Savant » Sat Oct 30, 2021 4:47 pm

^^^^^

Greed. It's a big part of it.


I shared a link to this in the prior page - worth sharing again.

Image
Image
https://twitter.com/AndersonAfDMdEP/sta ... 83910?s=20
User avatar
Belligerent Savant
 
Posts: 5573
Joined: Mon Oct 05, 2009 11:58 pm
Location: North Atlantic.
Blog: View Blog (0)

Re: Coronavirus Crisis: Main Thread

Postby stickdog99 » Sat Oct 30, 2021 7:56 pm

stickdog99
 
Posts: 6562
Joined: Tue Jul 12, 2005 5:42 am
Blog: View Blog (0)

Re: Coronavirus Crisis: Main Thread

Postby stickdog99 » Sat Oct 30, 2021 8:15 pm

stickdog99
 
Posts: 6562
Joined: Tue Jul 12, 2005 5:42 am
Blog: View Blog (0)

Re: Coronavirus Crisis: Main Thread

Postby Harvey » Sat Oct 30, 2021 11:01 pm

Belligerent Savant » Sat Oct 30, 2021 9:47 pm wrote:^^^^^

Greed. It's a big part of it.


Bilderberg back better.

https://www.lewrockwell.com/2021/04/bil ... -vanguard/

The sources below quote publicly available data, for all those who have a problem with either of them, I'm merely using these two for ease of reference.

Two companies appear to be the driving force behind everything happening in the world today, have a look and see how few big companies are not part owned by either one. Then take into account that one of these companies is more or less a wholly owned vehicle of the other. In short, one company controls the majority of the worlds wealth, everything. Finance, markets, housing, land, construction, big chemical, big pharma, insurance, mining, manufacturing, weapons, media, tech, communications, private education, private prisons, public relations, almost everything. Vanguard appears to be behind all of it.

https://www.naturalnews.com/2021-06-18-blackrock-vanguard-own-big-pharma-media.html

BlackRock and Vanguard are currently the top two owners of Time Warner, Comcast, Disney and News Corp. These four media conglomerates own and control more than 90 percent of the United States media landscape, which explains why their collective coverage of world events all centers around the same propaganda.

Though most people have never heard of them, BlackRock and Vanguard are also the silent monopoly owners of many other facets of the economy. They are said to hold ownership in some 1,600 American firms which, as of 2015, held combined revenues of $9.1 trillion.

If you add in State Street, BlackRock and Vanguard also have a stake in nearly 90 percent of all S&P 500 firms. Vanguard is also the largest shareholder of BlackRock – Vanguard having direct links to many of the world’s oldest and richest families.



https://childrenshealthdefense.org/defender/blackrock-vanguard-own-big-pharma-media/

According to Simply Wall Street, in February 2020, BlackRock and Vanguard were the two largest shareholders of GlaxoSmithKline, at 7% and 3.5% of shares respectively. At Pfizer, the ownership is reversed, with Vanguard being the top investor and BlackRock the second-largest stockholder.

Keep in mind that stock ownership ratios can change at any time, since companies buy and sell on a regular basis, so don’t get hung up on percentages. The bottom line is that BlackRock and Vanguard, individually and combined, own enough shares at any given time that we can say they easily control both Big Pharma and the centralized legacy media — and then some

Why does this matter? It matters because drug companies are driving COVID-19 responses — all of which, so far, have endangered rather than optimized public health — and mainstream media have been willing accomplices in spreading their propaganda, a false official narrative that has, and still is, leading the public astray and fosters fear based on lies.
And while we spoke of many things, fools and kings
This he said to me
"The greatest thing
You'll ever learn
Is just to love
And be loved
In return"


Eden Ahbez
User avatar
Harvey
 
Posts: 4200
Joined: Mon May 09, 2011 4:49 am
Blog: View Blog (20)

Re: Coronavirus Crisis: Main Thread

Postby drstrangelove » Sun Oct 31, 2021 5:46 am

Harvey » Sat Oct 30, 2021 11:01 pm wrote:
Belligerent Savant » Sat Oct 30, 2021 9:47 pm wrote:^^^^^

Greed. It's a big part of it.


Bilderberg back better.

https://www.lewrockwell.com/2021/04/bil ... -vanguard/

The sources below quote publicly available data, for all those who have a problem with either of them, I'm merely using these two for ease of reference.

Two companies appear to be the driving force behind everything happening in the world today, have a look and see how few big companies are not part owned by either one. Then take into account that one of these companies is more or less a wholly owned vehicle of the other. In short, one company controls the majority of the worlds wealth, everything. Finance, markets, housing, land, construction, big chemical, big pharma, insurance, mining, manufacturing, weapons, media, tech, communications, private education, private prisons, public relations, almost everything. Vanguard appears to be behind all of it.

https://www.naturalnews.com/2021-06-18-blackrock-vanguard-own-big-pharma-media.html

BlackRock and Vanguard are currently the top two owners of Time Warner, Comcast, Disney and News Corp. These four media conglomerates own and control more than 90 percent of the United States media landscape, which explains why their collective coverage of world events all centers around the same propaganda.

Though most people have never heard of them, BlackRock and Vanguard are also the silent monopoly owners of many other facets of the economy. They are said to hold ownership in some 1,600 American firms which, as of 2015, held combined revenues of $9.1 trillion.

If you add in State Street, BlackRock and Vanguard also have a stake in nearly 90 percent of all S&P 500 firms. Vanguard is also the largest shareholder of BlackRock – Vanguard having direct links to many of the world’s oldest and richest families.



https://childrenshealthdefense.org/defender/blackrock-vanguard-own-big-pharma-media/

According to Simply Wall Street, in February 2020, BlackRock and Vanguard were the two largest shareholders of GlaxoSmithKline, at 7% and 3.5% of shares respectively. At Pfizer, the ownership is reversed, with Vanguard being the top investor and BlackRock the second-largest stockholder.

Keep in mind that stock ownership ratios can change at any time, since companies buy and sell on a regular basis, so don’t get hung up on percentages. The bottom line is that BlackRock and Vanguard, individually and combined, own enough shares at any given time that we can say they easily control both Big Pharma and the centralized legacy media — and then some

Why does this matter? It matters because drug companies are driving COVID-19 responses — all of which, so far, have endangered rather than optimized public health — and mainstream media have been willing accomplices in spreading their propaganda, a false official narrative that has, and still is, leading the public astray and fosters fear based on lies.


BNY Mellon has $45.3 trillion in assets under custody and/or administration as of September 30, 2021 -
https://au.finance.yahoo.com/news/bny-m ... 00499.html

State Street with $42.6 trillion in assets under custody and/or administration and $3.9 trillion* in assets under management as of June 30, 2021 -
https://newsroom.statestreet.com/press- ... fault.aspx

JP Morgan Chase, $31.3 trillion in assets under custody as of the 1Q 2021 -
https://www.jpmorganchase.com/content/d ... 3e8804.pdf

Citibank, over $28 trillion in assets under custody as of 2021 -
https://finance.yahoo.com/news/citi-gro ... 00950.html


Four custodian banks. $146 trillion in assets which they can legally control. It was five about 6 months ago. Paribas(Rothschild) is up to about $15 trillion.

The S&P 500, the 500 largest publicly traded corporations amount to $40 trillion in assets.

Assumably the Rockefeller scions still control Citibank and JP Morgan Chase.
drstrangelove
 
Posts: 985
Joined: Sat May 22, 2021 10:43 am
Blog: View Blog (0)

Re: Coronavirus Crisis: Main Thread

Postby Harvey » Sun Oct 31, 2021 3:00 pm

Sure, but consider the truly vast number of companies in which both Blackrock and Vanguard are shareholders. Although it appears neither hold the largest stake in some of them, combined they hold a controlling block of shares in a staggering number. On paper it would appear other investors are the real power, but after recognising that Blackrock and Vanguard are really the same entity, an entirely different picture emerges. Look for yourself.
And while we spoke of many things, fools and kings
This he said to me
"The greatest thing
You'll ever learn
Is just to love
And be loved
In return"


Eden Ahbez
User avatar
Harvey
 
Posts: 4200
Joined: Mon May 09, 2011 4:49 am
Blog: View Blog (20)

Re: Coronavirus Crisis: Main Thread

Postby drstrangelove » Mon Nov 01, 2021 11:22 am

Vanguard and Blackrock are mutual funds, or asset managers. They actually transfer the voting rights of the stock they hold to the custodian banks, which then vote it via proxy to control corporate boards.

This system, strangely enough, is communism. Worker ownership over the means of production. Not control. Marx never said anything about control, only ownership. Corporations are the means of production. They are owned by the working classes through mutual funds. But are controlled by a custodianship of about five or so banking institutions through a network of these mutual funds.

No one outside the system appears to know this though. I mention it every chance I get but people seem rather disinterested in this revelation. Even though it literally demonstrates who controls the world(to the greatest extent) and how they control it.
drstrangelove
 
Posts: 985
Joined: Sat May 22, 2021 10:43 am
Blog: View Blog (0)

Re: Coronavirus Crisis: Main Thread

Postby Grizzly » Tue Nov 02, 2021 2:35 pm

https://thehighwire.com/watch/
Expert Panel on Medical Mandates & Vaccine Injuries (Featuring US Senator Ron Johnson, US Military Officials and Injured Civilians) Discusses Adverse Events Related To Mandated Covid-19 Vaccines
“The more we do to you, the less you seem to believe we are doing it.”

― Joseph mengele
User avatar
Grizzly
 
Posts: 4908
Joined: Wed Oct 26, 2011 4:15 pm
Blog: View Blog (0)

Re: Coronavirus Crisis: Main Thread

Postby streeb » Tue Nov 02, 2021 3:13 pm

BMJ:

Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial

Revelations of poor practices at a contract research company helping to carry out Pfizer’s pivotal covid-19 vaccine trial raise questions about data integrity and regulatory oversight. Paul D Thacker reports

In autumn 2020 Pfizer’s chairman and chief executive, Albert Bourla, released an open letter to the billions of people around the world who were investing their hopes in a safe and effective covid-19 vaccine to end the pandemic. “As I’ve said before, we are operating at the speed of science,” Bourla wrote, explaining to the public when they could expect a Pfizer vaccine to be authorised in the United States.1

But, for researchers who were testing Pfizer’s vaccine at several sites in Texas during that autumn, speed may have come at the cost of data integrity and patient safety. A regional director who was employed at the research organisation Ventavia Research Group has told The BMJ that the company falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer’s pivotal phase III trial. Staff who conducted quality control checks were overwhelmed by the volume of problems they were finding. After repeatedly notifying Ventavia of these problems, the regional director, Brook Jackson, emailed a complaint to the US Food and Drug Administration (FDA). Ventavia fired her later the same day. Jackson has provided The BMJ with dozens of internal company documents, photos, audio recordings, and emails.

Poor laboratory management
On its website Ventavia calls itself the largest privately owned clinical research company in Texas and lists many awards it has won for its contract work.2 But Jackson has told The BMJ that, during the two weeks she was employed at Ventavia in September 2020, she repeatedly informed her superiors of poor laboratory management, patient safety concerns, and data integrity issues. Jackson was a trained clinical trial auditor who previously held a director of operations position and came to Ventavia with more than 15 years’ experience in clinical research coordination and management. Exasperated that Ventavia was not dealing with the problems, Jackson documented several matters late one night, taking photos on her mobile phone. One photo, provided to The BMJ, showed needles discarded in a plastic biohazard bag instead of a sharps container box. Another showed vaccine packaging materials with trial participants’ identification numbers written on them left out in the open, potentially unblinding participants. Ventavia executives later questioned Jackson for taking the photos.

Early and inadvertent unblinding may have occurred on a far wider scale. According to the trial’s design, unblinded staff were responsible for preparing and administering the study drug (Pfizer’s vaccine or a placebo). This was to be done to preserve the blinding of trial participants and all other site staff, including the principal investigator. However, at Ventavia, Jackson told The BMJ that drug assignment confirmation printouts were being left in participants’ charts, accessible to blinded personnel. As a corrective action taken in September, two months into trial recruitment and with around 1000 participants already enrolled, quality assurance checklists were updated with instructions for staff to remove drug assignments from charts.

In a recording of a meeting in late September2020 between Jackson and two directors a Ventavia executive can be heard explaining that the company wasn’t able to quantify the types and number of errors they were finding when examining the trial paperwork for quality control. “In my mind, it’s something new every day,” a Ventavia executive says. “We know that it’s significant.”

Ventavia was not keeping up with data entry queries, shows an email sent by ICON, the contract research organisation with which Pfizer partnered on the trial. ICON reminded Ventavia in a September 2020 email: “The expectation for this study is that all queries are addressed within 24hrs.” ICON then highlighted over 100 outstanding queries older than three days in yellow. Examples included two individuals for which “Subject has reported with Severe symptoms/reactions … Per protocol, subjects experiencing Grade 3 local reactions should be contacted. Please confirm if an UNPLANNED CONTACT was made and update the corresponding form as appropriate.” According to the trial protocol a telephone contact should have occurred “to ascertain further details and determine whether a site visit is clinically indicated.”

Worries over FDA inspection
Documents show that problems had been going on for weeks. In a list of “action items” circulated among Ventavia leaders in early August 2020, shortly after the trial began and before Jackson’s hiring, a Ventavia executive identified three site staff members with whom to “Go over e-diary issue/falsifying data, etc.” One of them was “verbally counseled for changing data and not noting late entry,” a note indicates.

At several points during the late September meeting Jackson and the Ventavia executives discussed the possibility of the FDA showing up for an inspection (box 1). “We’re going to get some kind of letter of information at least, when the FDA gets here . . . know it,” an executive stated.

Box 1
A history of lax oversight
When it comes to the FDA and clinical trials, Elizabeth Woeckner, president of Citizens for Responsible Care and Research Incorporated (CIRCARE),3 says the agency’s oversight capacity is severely under-resourced. If the FDA receives a complaint about a clinical trial, she says the agency rarely has the staff available to show up and inspect. And sometimes oversight occurs too late.

In one example CIRCARE and the US consumer advocacy organisation Public Citizen, along with dozens of public health experts, filed a detailed complaint in July 2018 with the FDA about a clinical trial that failed to comply with regulations for the protection of human participants.4 Nine months later, in April 2019, an FDA investigator inspected the clinical site. In May this year the FDA sent the triallist a warning letter that substantiated many of the claims in the complaints. It said, “[I]t appears that you did not adhere to the applicable statutory requirements and FDA regulations governing the conduct of clinical investigations and the protection of human subjects.”5

“There’s just a complete lack of oversight of contract research organisations and independent clinical research facilities,” says Jill Fisher, professor of social medicine at the University of North Carolina School of Medicine and author of Medical Research for Hire: The Political Economy of Pharmaceutical Clinical Trials.

Ventavia and the FDA
A former Ventavia employee told The BMJ that the company was nervous and expecting a federal audit of its Pfizer vaccine trial.

“People working in clinical research are terrified of FDA audits,” Jill Fisher told The BMJ, but added that the agency rarely does anything other than inspect paperwork, usually months after a trial has ended. “I don’t know why they’re so afraid of them,” she said. But she said she was surprised that the agency failed to inspect Ventavia after an employee had filed a complaint. “You would think if there’s a specific and credible complaint that they would have to investigate that,” Fisher said.

In 2007 the Department of Health and Human Services’ Office of the Inspector General released a report on FDA’s oversight of clinical trials conducted between 2000 and 2005. The report found that the FDA inspected only 1% of clinical trial sites.6 Inspections carried out by the FDA’s vaccines and biologics branch have been decreasing in recent years, with just 50 conducted in the 2020 fiscal year.7


The next morning, 25 September 2020, Jackson called the FDA to warn about unsound practices in Pfizer’s clinical trial at Ventavia. She then reported her concerns in an email to the agency. In the afternoon Ventavia fired Jackson—deemed “not a good fit,” according to her separation letter.

Jackson told The BMJ it was the first time she had been fired in her 20 year career in research.


Concerns raised
In her 25 September email to the FDA Jackson wrote that Ventavia had enrolled more than 1000 participants at three sites. The full trial (registered under NCT04368728) enrolled around 44 000 participants across 153 sites that included numerous commercial companies and academic centres. She then listed a dozen concerns she had witnessed, including:

Participants placed in a hallway after injection and not being monitored by clinical staff
Lack of timely follow-up of patients who experienced adverse events
Protocol deviations not being reported
Vaccines not being stored at proper temperatures
Mislabelled laboratory specimens, and
Targeting of Ventavia staff for reporting these types of problems.
Within hours Jackson received an email from the FDA thanking her for her concerns and notifying her that the FDA could not comment on any investigation that might result. A few days later Jackson received a call from an FDA inspector to discuss her report but was told that no further information could be provided. She heard nothing further in relation to her report.


In Pfizer’s briefing document submitted to an FDA advisory committee meeting held on 10 December 2020 to discuss Pfizer’s application for emergency use authorisation of its covid-19 vaccine, the company made no mention of problems at the Ventavia site. The next day the FDA issued the authorisation of the vaccine.8

In August this year, after the full approval of Pfizer’s vaccine, the FDA published a summary of its inspections of the company’s pivotal trial. Nine of the trial’s 153 sites were inspected. Ventavia’s sites were not listed among the nine, and no inspections of sites where adults were recruited took place in the eight months after the December 2020 emergency authorisation. The FDA’s inspection officer noted: “The data integrity and verification portion of the BIMO [bioresearch monitoring] inspections were limited because the study was ongoing, and the data required for verification and comparison were not yet available to the IND [investigational new drug].”

Other employees’ accounts
In recent months Jackson has reconnected with several former Ventavia employees who all left or were fired from the company. One of them was one of the officials who had taken part in the late September meeting. In a text message sent in June the former official apologised, saying that “everything that you complained about was spot on.”

Two former Ventavia employees spoke to The BMJ anonymously for fear of reprisal and loss of job prospects in the tightly knit research community. Both confirmed broad aspects of Jackson’s complaint. One said that she had worked on over four dozen clinical trials in her career, including many large trials, but had never experienced such a “helter skelter” work environment as with Ventavia on Pfizer’s trial.


“I’ve never had to do what they were asking me to do, ever,” she told The BMJ. “It just seemed like something a little different from normal—the things that were allowed and expected.”

She added that during her time at Ventavia the company expected a federal audit but that this never came.

After Jackson left the company problems persisted at Ventavia, this employee said. In several cases Ventavia lacked enough employees to swab all trial participants who reported covid-like symptoms, to test for infection. Laboratory confirmed symptomatic covid-19 was the trial’s primary endpoint, the employee noted. (An FDA review memorandum released in August this year states that across the full trial swabs were not taken from 477 people with suspected cases of symptomatic covid-19.)

“I don’t think it was good clean data,” the employee said of the data Ventavia generated for the Pfizer trial. “It’s a crazy mess.”

A second employee also described an environment at Ventavia unlike any she had experienced in her 20 years doing research. She told The BMJ that, shortly after Ventavia fired Jackson, Pfizer was notified of problems at Ventavia with the vaccine trial and that an audit took place.

Since Jackson reported problems with Ventavia to the FDA in September 2020, Pfizer has hired Ventavia as a research subcontractor on four other vaccine clinical trials (covid-19 vaccine in children and young adults, pregnant women, and a booster dose, as well an RSV vaccine trial; NCT04816643, NCT04754594, NCT04955626, NCT05035212). The advisory committee for the Centers for Disease Control and Prevention is set to discuss the covid-19 paediatric vaccine trial on 2 November.


https://www.bmj.com/content/375/bmj.n2635
User avatar
streeb
 
Posts: 1061
Joined: Thu Feb 09, 2006 9:19 pm
Location: Zona, BC
Blog: View Blog (0)

PreviousNext

Return to General Discussion

Who is online

Users browsing this forum: No registered users and 2 guests